Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

Psych CASC / OSCEAddiction psychiatry — substance use disorders

Psych CASC / OSCE · Addiction psychiatry — substance use disorders

Explain methadone, buprenorphine, COWS, and naloxone — CASC communication station

MRCPsych/FRANZCP-style communication station: explain withdrawal staging, OAT rationale, precipitated withdrawal timing, methadone vs buprenorphine, and naloxone training against unsafe detox pressure.

communication2 min readSource-verified ·

Target exams

FRANZCPMRCPsychABPNMD-DNB
On this page
Study tools

Target exams

FRANZCPMRCPsychABPNMD-DNB
Prompt
A 26-year-old woman with heroin dependence is day 1 post-overdose. She is in moderate withdrawal (COWS 14). She fears 'methadone is liquid handcuffs' and her sister wants rapid home detox with 'Nurofen and willpower.' You propose buprenorphine–naloxone induction and take-home naloxone.

Candidate brief

Format. Communication station. You are the psychiatry or addiction registrar. The examiner may play the patient, her sister, or both.

Candidate instructions. Explain opioid withdrawal and why medication treatment is recommended after overdose. Describe COWS in plain language. Compare methadone and buprenorphine. Explain why buprenorphine is started only once she is clearly withdrawing. Teach naloxone use. Negotiate against unsafe rapid home detox. Check understanding.

Psychiatry Fellowship Pro

Continue reading

You have read the opening of this CASC / OSCE. The complete unit — every section and its primary-source references — is part of the Psychiatry Fellowship fellowship library.

Sign in to continueSee pricing
References8ShowHide
  1. [1]D'Onofrio G, O'Connor PG, Pantalon MV, et al. Emergency department-initiated buprenorphine/naloxone treatment for opioid dependence: a randomized clinical trial JAMA, 2015.PMID 25919527
  2. [2]Sordo L, Barrio G, Bravo MJ, et al. Mortality risk during and after opioid substitution treatment BMJ, 2017.PMID 28446428
  3. [4]Boyer EW Management of opioid analgesic overdose N Engl J Med, 2012.PMID 22784117
  4. [5]Wesson DR, Ling W The Clinical Opiate Withdrawal Scale (COWS) J Psychoactive Drugs, 2003.PMID 12924748
  5. [6]National Institute for Health and Care Excellence Drug misuse in over 16s: opioid detoxification (CG52) NICE clinical guideline CG52, 2007.Source
  6. [7]US National Library of Medicine DailyMed METHADONE HYDROCHLORIDE TABLET [AMERICAN HEALTH PACKAGING] DailyMed, 2026.Source
  7. [8]US National Library of Medicine DailyMed SUBOXONE (BUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE) FILM, SOLUBLE [INDIVIOR INC.] DailyMed, 2026.Source
  8. [9]US National Library of Medicine DailyMed NALOXONE HYDROCHLORIDE INJECTION [DR. REDDY'S LABORATORIES, INC.] DailyMed, 2026.Source
Psychiatry Fellowship Pro

$29/ monthor $279 / year

The complete Psychiatry Fellowship library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousExplain medical work-up for new psychosis to a worried partner — CASC communication stationGeneral adult psychiatry — secondary / organic psychosisNextExplain opioid agonist treatment and naloxone — CASC communication stationAddiction psychiatry — substance use disorders